Literature DB >> 21412246

Familial skewed X-chromosome inactivation linked to a component of the cohesin complex, SA2.

Nisa K E Renault1, Marc P Renault, Emily Copeland, Robin E Howell, Wenda L Greer.   

Abstract

The gene dosage inequality between females with two X-chromosomes and males with one is compensated for by X-chromosome inactivation (XCI), which ensures the silencing of one X in every somatic cell of female mammals. XCI in humans results in a mosaic of two cell populations: those expressing the maternal X-chromosome and those expressing the paternal X-chromosome. We have previously shown that the degree of mosaicism (the X-inactivation pattern) in a Canadian family is directly related to disease severity in female carriers of the X-linked recessive bleeding disorder, haemophilia A. The distribution of X-inactivation patterns in this family was consistent with a genetic trait having a co-dominant mode of inheritance, suggesting that XCI choice may not be completely random. To identify genetic elements that could be responsible for biased XCI choice, a linkage analysis was undertaken using an approach tailored to accommodate the continuous nature of the X-inactivation pattern phenotype in the Canadian family. Several X-linked regions were identified, one of which overlaps with a region previously found to be linked to familial skewed XCI. SA2, a component of the cohesin complex is identified as a candidate gene that could participate in XCI through its association with CTCF.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21412246     DOI: 10.1038/jhg.2011.25

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  4 in total

1.  Human X-chromosome inactivation pattern distributions fit a model of genetically influenced choice better than models of completely random choice.

Authors:  Nisa K E Renault; Sonja M Pritchett; Robin E Howell; Wenda L Greer; Carmen Sapienza; Karen Helene Ørstavik; David C Hamilton
Journal:  Eur J Hum Genet       Date:  2013-05-08       Impact factor: 4.246

2.  De novo loss-of-function variants in STAG2 are associated with developmental delay, microcephaly, and congenital anomalies.

Authors:  Sureni V Mullegama; Steven D Klein; Milene V Mulatinho; Tharanga Niroshini Senaratne; Kathryn Singh; Dzung C Nguyen; Natalie M Gallant; Samuel P Strom; Shahnaz Ghahremani; Nagesh P Rao; Julian A Martinez-Agosto
Journal:  Am J Med Genet A       Date:  2017-03-11       Impact factor: 2.578

Review 3.  Cohesin complexes with a potential to link mammalian meiosis to cancer.

Authors:  Alexander Strunnikov
Journal:  Cell Regen (Lond)       Date:  2013-06-18

4.  Heterozygous Deletion of the SHOX Gene Enhancer in two Females With Clinical Heterogeneity Associating With Skewed XCI and Escaping XCI.

Authors:  Yixi Sun; Yuqin Luo; Yeqing Qian; Min Chen; Liya Wang; Hongge Li; Yu Zou; Minyue Dong
Journal:  Front Genet       Date:  2019-11-06       Impact factor: 4.599

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.